Lipella Pharmaceuticals Inc (LIPO)

Currency in USD
0.0209
-0.0291(-58.20%)
Closed·
Unusual trading volume
LIPO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.02090.0400
52 wk Range
0.01973.1700
Key Statistics
Prev. Close
0.05
Open
0.04
Day's Range
0.0209-0.04
52 wk Range
0.0197-3.17
Volume
100.05K
Average Volume (3m)
23.28K
1-Year Change
-99.169%
Book Value / Share
0.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIPO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LIPO Income Statement

Compare LIPO to Peers and Sector

Metrics to compare
LIPO
Peers
Sector
Relationship
P/E Ratio
0.0x−3.2x−0.5x
PEG Ratio
0.000.120.00
Price/Book
0.1x2.3x2.6x
Price / LTM Sales
0.2x126.2x3.2x
Upside (Analyst Target)
-111.6%48.1%
Fair Value Upside
Unlock1.8%6.6%Unlock

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.

People Also Watch

77.49
BLLN
+3.25%
8.80
WSHP
-3.61%
0.76
ARAI
+8.58%
0.57
JBDI
0.00%
0.010
CREVF
0.00%

FAQ

What Is the Lipella Pharmaceuticals (LIPO) Stock Price Today?

The Lipella Pharmaceuticals stock price today is 0.0209 USD.

What Stock Exchange Does Lipella Pharmaceuticals Trade On?

Lipella Pharmaceuticals is listed and trades on the OTC Markets.

What Is the Stock Symbol for Lipella Pharmaceuticals?

The stock symbol for Lipella Pharmaceuticals is "LIPO."

What Is the Lipella Pharmaceuticals Market Cap?

As of today, Lipella Pharmaceuticals market cap is 96.5800K USD.

What Is Lipella Pharmaceuticals's Earnings Per Share (TTM)?

The Lipella Pharmaceuticals EPS (TTM) is -1.7592.

When Is the Next Lipella Pharmaceuticals Earnings Date?

Lipella Pharmaceuticals will release its next earnings report on Jun 03, 2026.

From a Technical Analysis Perspective, Is LIPO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lipella Pharmaceuticals Stock Split?

Lipella Pharmaceuticals has split 1 times.

How Many Employees Does Lipella Pharmaceuticals Have?

Lipella Pharmaceuticals has 6 employees.

What is the current trading status of Lipella Pharmaceuticals (LIPO)?

As of May 03, 2026, Lipella Pharmaceuticals (LIPO) is trading at a price of 0.0209 USD, with a previous close of 0.0500 USD. The stock has fluctuated within a day range of 0.0209 USD to 0.0400 USD, while its 52-week range spans from 0.0197 USD to 3.1700 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.